#AI drug discovery

All articles tagged with "AI drug discovery"

DT Editorial Team·Apr 24, 2026·via wired.com

Candidate metadata says Lilly signed a commercialization deal with Insilico Medicine.
The agreement includes $115 million upfront.
The total potential value is approximately $2.75 billion.

DT Editorial Team·Mar 29, 2026·via statnews.com

Lilly and Insilico Medicine signed a deal worth up to $2.75 billion.
Insilico will receive $115 million upfront, with most value tied to milestones and license fees.
The companies have worked together since 2023.
Insilico says it has developed at least 28 drugs using generative AI, with nearly half in clinical trials.

DT Editorial Team·Mar 29, 2026·via the-decoder.com

César de la Fuente uses AI to find antibiotic compounds in extinct organism genomes, including Neanderthals and woolly mammoths
Machine learning models can scan millions of peptide sequences in days, compared to thousands per year with traditional methods
The human proteome contains previously unrecognized antimicrobial compounds that AI has now identified
Antimicrobial resistance kills 1.27 million people annually while the new antibiotic pipeline has nearly dried up
New funding models including government pull incentives are needed to bring AI-discovered antibiotics to patients

DT Editorial Team·Feb 17, 2026·5 min read·via technologyreview.com

Criminal networks use relay devices, CAN bus injectors, and GPS jammers to steal luxury vehicles at scale
César de la Fuente uses AI to discover potential antibiotics from extinct organisms, human proteins, and metagenomic data
Antimicrobial resistance kills an estimated 1.27 million people annually, and the new drug pipeline has slowed dramatically
AI can evaluate millions of candidate molecules far faster than traditional screening methods
Both stories highlight how morally neutral technology can serve destructive or life-saving purposes

DT Editorial Team·Feb 17, 2026·4 min read·via technologyreview.com